FRAZIER LIFE SCIENCES
Frazier Life Sciences invests in and builds companies developing and commercializing novel therapeutics at all stages, from company formation to public.
FRAZIER LIFE SCIENCES
Founded:
1991-01-01
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-09 | Aspen Neuroscience | Frazier Life Sciences investment in Series B - Aspen Neuroscience | 147.5 M USD |
| 2022-04-07 | Trevi Therapeutics | Frazier Life Sciences investment in Post-IPO Equity - Trevi Therapeutics | 55 M USD |
More informations about "Frazier Life Sciences"
Team - Frazier Life Sciences
Operating Professionals and Senior Advisors are not employees of Frazier Life Sciences but provide advisory and consulting services to Frazier and often serve in operational positions …See details»
Strategy - Frazier Life Sciences
Our latest Venture Fund is Frazier Life Sciences XI, a $987 million fund that was raised in 2022. FEATURED COMPANY. Lengo was a Frazier-founded company, with the idea that there was an opportunity to discover and develop a CNS …See details»
Frazier Life Sciences - Crunchbase Investor Profile
Frazier Life Sciences IX is a venture capital fund. Frazier Life Sciences invests in and builds companies developing and commercializing novel therapeutics at all stages, from company formation to public. Lists Featuring This Company. Edit …See details»
Frazier Life Sciences - Crunchbase Investor Profile & Investments
Frazier Life Sciences invests in late-stage biotechnology and healthcare companies, focusing on therapeutics. Their investment strategy spans North America and Europe, with key locations in …See details»
Frazier Life Sciences - LinkedIn
Frazier Life Sciences manages over $3.9 billion in capital, including venture funds focusing on company creation and private companies, and a public fund focused on small and mid-cap public companies.See details»
Frazier Life Sciences - Funding, Financials, Valuation & Investors
Frazier Life Sciences has raised a total of $1.7B across 4 funds, their latest being Frazier Life Sciences Public Overage Fund. This fund was announced on Apr 14, 2022 and raised a total …See details»
Frazier Life Sciences - Company Profile & Staff Directory
Frazier Life Sciences invests globally in private and publicly-traded companies that discover, develop, and commercialize innovative biopharmaceuticals. Frazier Life Sciences funds …See details»
Frazier Life Sciences - Investments, Portfolio & Company Exits
Frazier Life Sciences has made 2 diversity investments. Their most recent diversity investment was on Feb 27, 2024, when Applied Therapeutics raised. obfuscated. obfuscated. Announced …See details»
Frazier Life Sciences Closes $987 Million Venture Fund …
Mar 16, 2022 Frazier Life Sciences funds comprise over $3.1 billion in capital raised (as of March 2022), including venture funds focusing on company creation and private companies, and a public fund focused ...See details»
Frazier Life Sciences - VentureRadar
Frazier Life Sciences has facilitated over 40 FDA-approved therapeutics since 2010, partnering closely with entrepreneurs to advance new treatment options for patients. VentureRadar …See details»
Frazier Life Sciences Adds Over $630 Million to Evergreen Public …
Frazier Life Sciences manages over $3.9 billion in capital, including Venture Funds focusing on company creation and private companies and the long-only Public Fund focused on small- and …See details»
Portfolio - Frazier Life Sciences
Leaders in Therapeutics Development . Our portfolio companies range from seed-stage startups to publicly traded companies* and are advancing novel therapeutics for patients with a wide …See details»
With $987M round, Frazier looks to form several new biotechs this …
Mar 16, 2022 With a new $987 million fund, Frazier Life Sciences is ready to form another four or five new biotechs over the next 12 months and bankroll early-stage investing in other …See details»
Frazier Life Sciences Adds Over $630 Million to Evergreen Public …
Oct 2, 2024 Frazier Life Sciences manages over $3.9 billion in capital, including Venture Funds focusing on company creation and private companies and the long-only Public Fund focused …See details»
Frazier closes $617M life sciences fund, creating scope for bigger …
Jan 17, 2020 Two-thirds of Frazier Life Sciences X will go into seed and series A rounds. The tenth fund is significantly bigger than its predecessor, which topped out at $419 million in 2017.See details»
Frazier Life Sciences - Updates, News, Events, Signals & Triggers
Life-sciences-europe.com — Alentis Therapeutics–Frazier: investment, 202411 financing round Series D totalling $181.4m incl new + co-investor Frazier Life Sciences News • Nov 12, 2024 …See details»
Frazier Life Sciences Strengthens Investment Team with Addition …
PALO ALTO, Calif. January 4, 2024 – Frazier Life Sciences (FLS), a longstanding venture capital firm investing in innovative biopharmaceuticals, proudly welcomes Lin Mu, M.D., MBA as a …See details»
Frazier Life Sciences - Contacts, Employees, Board Members
Frazier Life Sciences has 2 current employee profiles, including Vice President of Company Creation Lauren Mifflin. Contacts. Edit Contacts Section. Job Department. Protected Content. …See details»
Frazier Life Sciences - Contacts, Employees, Board Members
Frazier Life Sciences has 1 current employee profile, Venture Partner Tao Fu. Contacts. Edit Contacts Section. Job Department. Protected Content. Partner and General Counsel, Life …See details»